What Is the Connection Between Iron and Diabetes?

Excess iron in the body raises the risk of type 2 diabetes, and the relationship works through several biological pathways at once. Large prospective studies consistently show that people with higher iron stores, measured by the blood protein ferritin, develop diabetes at significantly elevated rates. A dose-response meta-analysis found that for every 100-microgram-per-liter increase in ferritin, type 2 diabetes risk rose by about 22 percent overall, with the effect roughly twice as strong in women as in men.¹ But the iron-diabetes story is not one-directional. Iron deficiency also complicates diabetes management, and diabetes itself can contribute to iron problems. The relationship is tangled enough that understanding it changes how you think about diet, supplements, and even routine blood tests.

How Iron Stores Predict Diabetes Risk

The evidence linking higher iron to future diabetes comes from several large cohort studies, not just cross-sectional snapshots. In the Nurses’ Health Study, researchers tracked apparently healthy women and found that those in the top fifth of ferritin levels had roughly triple the risk of developing type 2 diabetes compared to those in the lowest fifth, even after accounting for body weight, family history, physical activity, and diet.² The EPIC-Norfolk study in Europe found something similar: participants with clinically elevated ferritin had over seven times the odds of developing diabetes after adjusting for standard risk factors. Even after further adjustment for markers of inflammation and liver function, the odds remained more than three times higher.³

These findings are not driven by people with rare iron overload diseases. The increased risk shows up across the normal range of ferritin values, suggesting that even moderately elevated iron stores matter. Ferritin is an imperfect marker because it rises with inflammation, but the associations held up after researchers controlled for inflammatory markers like C-reactive protein, which argues against the link being just an artifact of chronic inflammation.

What Excess Iron Does to the Pancreas

The insulin-producing beta cells in the pancreas are particularly vulnerable to iron-driven damage. These cells naturally produce elevated levels of reactive oxygen species as a byproduct of their metabolic work, and they have relatively weak antioxidant defenses compared to other cell types. When iron accumulates in beta cells, it catalyzes reactions that generate additional free radicals, amplifying oxidative stress in cells that are already poorly equipped to handle it.⁴ The result is impaired insulin production and, eventually, beta-cell death.

Recent research has connected this process to ferroptosis, a specific form of cell death driven by iron-dependent lipid damage. In lab models of diabetes, beta cells showed hallmarks of ferroptosis: accumulating iron and lipid peroxides while losing their protective antioxidant enzymes. Blocking ferroptosis with a drug called ferrostatin-1 rescued beta cells and protected pancreatic islets from damage in diabetic mice.⁵ This is still mostly lab science, but it points toward a specific mechanism through which iron kills the cells responsible for making insulin.

Iron and Insulin Resistance in the Liver

Beyond damaging beta cells, excess iron also makes the body’s tissues less responsive to insulin, particularly in the liver. In mouse models, increased liver iron triggered oxidative stress and lipid damage that interfered with insulin signaling, leading the liver to ramp up its own glucose production and fat synthesis — exactly the metabolic pattern seen in type 2 diabetes.⁶ A separate study found that iron overload in liver cells triggered ferroptosis through a specific signaling pathway, and that using an iron-chelating drug (deferasirox) improved insulin resistance.⁷

The liver is the body’s largest iron storage depot, so it makes sense that this organ would bear the brunt of iron overload. But the effects ripple outward. High-iron diets in animal studies also lowered adiponectin, a hormone released by fat tissue that normally helps keep cells sensitive to insulin. Mice fed a high-iron diet had significantly reduced glucose disposal per gram of lean tissue, a direct measure of worsening insulin resistance.⁸ These animal findings help explain why the human epidemiological data consistently links higher iron to diabetes: iron seems to attack glucose control from multiple angles simultaneously.

Interestingly, the timeline of liver damage appears to develop in stages. A study feeding mice a high-iron diet found that liver insulin signaling remained intact after three days and one week, but was markedly impaired by three weeks. Skeletal muscle, by contrast, stayed responsive to insulin throughout the same period, and whole-body glucose clearance was preserved in the short term.⁹ This suggests the liver is the first domino to fall, and that systemic glucose problems may take longer to appear on standard tests even after liver damage has started.

Hemochromatosis and “Bronze Diabetes”

The most dramatic version of the iron-diabetes connection plays out in hereditary hemochromatosis, a genetic condition in which the body absorbs far too much iron from food. Roughly half of people diagnosed with hemochromatosis develop either type 1 or type 2 diabetes due to direct iron damage to the beta cells and worsening insulin resistance.¹⁰ The condition was historically called “bronze diabetes” because of the skin darkening caused by iron deposits.

But the diabetes risk in hemochromatosis is not purely about iron quantity. It involves a mix of factors including body weight, family history of diabetes, liver damage (particularly cirrhosis), and metabolic syndrome.¹¹ When researchers tested glucose metabolism directly in hemochromatosis patients, they found that those with impaired glucose tolerance had a roughly 68 percent drop in their acute insulin response to glucose compared to those with normal tolerance, yet they were not more insulin resistant. People who had progressed to full diabetes showed further declines in insulin response, insulin resistance, or both.¹² In other words, the primary problem in hemochromatosis diabetes appears to be failing insulin production rather than tissue resistance, though resistance can pile on later.

Heme Iron Versus Non-Heme Iron in Food

Not all dietary iron carries the same risk. Iron in food comes in two forms: heme iron, found in meat, poultry, and fish; and non-heme iron, found in plants, fortified grains, and supplements. Multiple meta-analyses have found that heme iron intake is consistently linked to higher diabetes risk, while non-heme iron, total dietary iron, and supplemental iron are not.¹³ The body absorbs heme iron much more efficiently than non-heme iron, which may explain why it is more likely to push iron stores into a harmful range.

A large 2024 study integrated dietary data with blood biomarker analysis and confirmed that heme iron intake was associated with about a 26 percent higher risk of type 2 diabetes when comparing the highest to lowest intake groups, while non-heme iron showed no such association.¹⁴ Research disentangling the effects of meat from the effects of heme iron found that both red meat and its heme iron content independently contributed to diabetes risk. For poultry, the association with diabetes was entirely explained by its heme iron content; once heme iron was accounted for, poultry intake alone was no longer significantly linked to the disease.¹⁵

This does not mean you need to avoid meat entirely. The risk increases are modest per serving, and context matters. But if you already have borderline glucose issues or elevated ferritin, the heme-iron distinction is worth knowing about. Swapping some red meat for plant-based protein or fish would reduce heme iron intake without requiring a dramatic dietary overhaul.

Blood Donation as a Natural Experiment

One of the more compelling pieces of evidence that iron truly causes the metabolic changes, rather than just accompanying them, comes from blood donation studies. Frequent blood donors naturally deplete their iron stores over time. In a study comparing frequent donors (two to ten donations) to non-donors, the donors had significantly higher insulin sensitivity and lower ferritin, despite having the same hemoglobin levels and blood counts. Their lower iron stores were directly associated with better insulin action.¹⁶ This finding suggests that reducing iron improves metabolic function even in healthy people who do not have a diagnosable iron overload condition.

The idea of deliberately reducing iron to improve glucose control has also been tested with pharmaceutical iron chelators. In animal studies, the drug deferoxamine improved glucose clearance, boosted insulin receptor activity, and enhanced insulin signaling in liver tissue. Rats on a high-fat, high-calorie diet showed better glucose handling when iron was depleted and worse glucose handling when iron was supplemented.¹⁷ Iron chelation therapy is standard treatment for hemochromatosis, but these findings hint that targeted iron reduction could have broader metabolic benefits — though clinical trials in humans with ordinary diabetes are still limited.

The Opposite Problem: Iron Deficiency and Misleading Blood Sugar Tests

Iron’s relationship with diabetes is not simply “more iron, more risk.” Iron deficiency creates its own diabetes-related complications, particularly by distorting HbA1c, the test most commonly used to diagnose and monitor diabetes. HbA1c measures how much glucose has attached to hemoglobin over the past two to three months. When you are iron deficient, your red blood cells live longer and their hemoglobin undergoes more glycation, which pushes HbA1c readings higher than they should be for your actual blood sugar levels.¹⁸

In one study of iron-deficient individuals with controlled blood glucose, HbA1c averaged 6.8 percent — a level that would normally suggest pre-diabetes or poorly managed diabetes — even though their actual glucose was under control. The elevation was more pronounced in women.¹⁹ This has real consequences: a person with undiagnosed iron deficiency might be told they have diabetes when they do not, or a diabetic patient with iron-deficiency anemia might have their medication unnecessarily increased based on a falsely high HbA1c.

Iron deficiency is common among people who already have diabetes, too. In one cohort, about 40 percent of diabetic patients had iron-deficiency anemia. Those with anemia had higher HbA1c values and spent more time in hyperglycemic ranges on continuous glucose monitoring.²⁰ The chronic low-grade inflammation of diabetes itself promotes iron deficiency through several routes, including elevated levels of hepcidin (a hormone that blocks iron absorption) and inflammatory molecules that shorten red blood cell survival.²¹ So diabetes can cause iron deficiency, which in turn makes diabetes harder to monitor accurately — a frustrating loop.

Iron Supplements During Pregnancy and Gestational Diabetes

Pregnancy is a setting where the iron-diabetes tension gets particularly tricky. Pregnant women routinely take iron supplements to prevent anemia, but several studies have found that iron supplementation in women who are already iron-replete may increase the risk of gestational diabetes. One study found that iron supplement users during midpregnancy had a two- to threefold higher risk of gestational diabetes, insulin resistance, and metabolic syndrome, even after adjusting for multiple risk factors.²²

The overall picture is still unsettled. A narrative review of fourteen studies found that several reported significant associations between iron supplementation and increased gestational diabetes risk, but the evidence was somewhat contradictory, and meta-analyses have flagged substantial differences between studies. The effect, if real, appears relatively small in magnitude.²³ A review in the American Journal of Clinical Nutrition noted that many of these studies assessed iron supplementation at the same time as diabetes diagnosis, making it hard to tell whether the supplements preceded the disease or were prescribed because of symptoms that overlapped with early diabetes.²⁴

The practical takeaway is that iron supplementation during pregnancy should be guided by actual iron status rather than given as a blanket recommendation. Women who are already iron-sufficient or who have elevated ferritin may not benefit from additional iron, and there is at least a plausible biological reason to think it could nudge glucose levels in the wrong direction.

Why the Risk Is Stronger in Women

The sex difference in the iron-diabetes relationship is striking. The dose-response meta-analysis mentioned earlier found that women’s diabetes risk roughly doubled that of men at the same ferritin level.¹ One explanation involves menopause. Before menopause, regular menstrual blood loss keeps women’s iron stores lower than men’s. After menopause, iron accumulates, and transferrin levels change. Research presented at a European cardiology conference found that changes in transferrin levels could partly explain the increased type 2 diabetes risk observed after menopause.²⁵

This also helps explain an evolutionary curiosity. The most common hemochromatosis mutation, C282Y, is especially prevalent in populations of northern European descent. One theory suggests the mutation persisted because it offered an advantage against iron-deficiency anemia during centuries of grain-heavy, meat-poor diets and frequent blood loss from childbirth and parasites. In an era of iron-fortified food and less blood loss, that same mutation has become a liability.²⁶

Iron and Diabetic Complications in the Eyes

The connection between iron and diabetes does not stop at disease onset. In people who already have diabetes, iron accumulation in the retina appears to worsen diabetic eye disease. High blood sugar damages heme molecules, releasing free iron into retinal tissue. Bleeding within the retina and overactivity of the renin-angiotensin system compound the problem. The resulting iron overload drives oxidative damage to retinal neurons, accelerates the formation of advanced glycation end products, and impairs the retinal pigment cells that normally keep the tissue clean.²⁷ Whether iron reduction could slow retinal damage in diabetes is an open question, but the biology is suggestive enough to make it an active area of research.

Better Ways to Measure Iron Status in People with Diabetes

Ferritin is the most commonly ordered test for iron stores, but it has a significant weakness in anyone with diabetes: it rises with inflammation, and type 2 diabetes is a state of chronic low-grade inflammation. That means a high ferritin reading in someone with diabetes might reflect genuine iron overload, or it might just reflect the inflammatory environment. One study found that correcting for the inflammatory marker C-reactive protein wiped out ferritin’s correlation with metabolic outcomes in women with type 2 diabetes.²⁸

An alternative marker is the soluble transferrin receptor-to-ferritin ratio, which is less influenced by inflammation and may give a clearer picture of actual iron stores in people with metabolic disease.²⁹ If you have diabetes and your doctor is tracking your iron levels, it is worth asking whether a single ferritin number tells the whole story, especially if you also have elevated inflammatory markers. The measurement challenge is one reason the iron-diabetes connection has taken decades to sort out: the standard tools for measuring iron are muddied by the very disease researchers are trying to study.